Free Newsletter
Drug supply changes imminent
The U.S. government and other parties are stepping up efforts to protect the national drug distribution system from counterfeiting, terrorism and disruption from manmade and natural disasters, says a new report. Challenges include the dominance of three wholesalers, growth of mail order and the wave of pharmacy consolidation. "The U.S. supply chain is set to undergo great changes in the next decade," authors say. Summary
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
